| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −15.8× | −1.7× | |
| Price / Book | 8.2× | 2.0× | |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | −19.6× | −1.5× | |
| EV / EBITDA | −16.0× | −1.2× | |
| Earnings yield | −6.3% | −14.4% | |
| Free cash flow yield | −5.1% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,284.61 | +3.57% | $1.21T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $258.75 | +1.95% | $623.56B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $288.72 | +2.14% | $510.2B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $419.60 | +3.13% | $376.63B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.38 | +3.31% | $366.08B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.43 | +2.15% | $282.85B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.78 | +2.95% | $261.76B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $691.99 | +1.86% | $255.86B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $435.10 | +2.39% | $235.23B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.89 | +1.84% | $193.29B | 22.3× | 37.5% | +29.9% |
